Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2011 Dec 01;806:965-78. doi: 10.1124/mol.111.071225.
Show Gene links
Show Anatomy links
2-Aminoethyl methylphosphonate, a potent and rapidly acting antagonist of GABA(A)-ρ1 receptors.
Xie A, Yan J, Yue L, Feng F, Mir F, Abdel-Halim H, Chebib M, Le Breton GC, Standaert RF, Qian H, Pepperberg DR.
???displayArticle.abstract???
2-Aminoethyl methylphosphonate (2-AEMP), an analog of GABA, has been found to exhibit antagonist activity at GABA(A)-ρ1 (also known as ρ1 GABA(C)) receptors. The present study was undertaken to elucidate 2-AEMP's action and to test the activities of 2-AEMP analogs. Whole-cell patch-clamp techniques were used to record membrane currents in neuroblastoma cells stably transfected with human GABA(A)-ρ1 receptors. The action of 2-AEMP was compared with that of 1,2,5,6-tetrahydropyridin-4-yl methylphosphinic acid (TPMPA), a commonly used GABA(A)-ρ1 antagonist. With 10 μM GABA, 2-AEMP's IC(50) (18 μM) differed by less than 2.5-fold from that of TPMPA (7 μM), and results obtained were consistent with a primarily competitive mode of inhibition by 2-AEMP. Terminating the presentation of 2-AEMP or TPMPA in the presence of GABA produced a release from inhibition. However, the rate of inhibition release upon the termination of 2-AEMP considerably exceeded that determined with termination of TPMPA. Moreover, when presented at concentrations near their respective IC(50) values, the preincubation period associated with 2-AEMP's onset of inhibition was much shorter than that for TPMPA. Analogs of 2-AEMP possessing a benzyl or n-butyl rather than a methyl substituent at the phosphorus atom, as well as analogs bearing a C-methyl substituent on the aminoethyl side chain, exhibited reduced potency relative to 2-AEMP. Of these analogs, only (R)-2-aminopropyl methylphosphonate significantly diminished the response to 10 μM GABA. Structure-activity relationships are discussed in the context of molecular modeling of ligand binding to the antagonist binding site of the GABA(A)-ρ1 receptor.
Abdel-Halim,
A molecular basis for agonist and antagonist actions at GABA(C) receptors.
2008, Pubmed
Abdel-Halim,
A molecular basis for agonist and antagonist actions at GABA(C) receptors.
2008,
Pubmed Amin,
Homomeric rho 1 GABA channels: activation properties and domains.
1994,
Pubmed
,
Xenbase Amin,
Insights into the activation mechanism of rho1 GABA receptors obtained by coexpression of wild type and activation-impaired subunits.
1996,
Pubmed
,
Xenbase Cates,
Phosphorus analogues of gamma-aminobutyric acid, a new class of anticonvulsants.
1984,
Pubmed Chang,
Channel opening locks agonist onto the GABAC receptor.
1999,
Pubmed Chebib,
GABAC receptor ion channels.
2004,
Pubmed Chebib,
(3-Aminocyclopentyl)methylphosphinic acids: novel GABA(C) receptor antagonists.
2007,
Pubmed
,
Xenbase Chebib,
Analogues of gamma-aminobutyric acid (GABA) and trans-4-aminocrotonic acid (TACA) substituted in the 2 position as GABAC receptor antagonists.
1997,
Pubmed
,
Xenbase Chowdhury,
Phosphonic acid analogs of GABA through reductive dealkylation of phosphonic diesters with lithium trialkylborohydrides.
2007,
Pubmed
,
Xenbase Clements,
The time course of glutamate in the synaptic cleft.
1992,
Pubmed Enz,
Expression of GABA receptor rho 1 and rho 2 subunits in the retina and brain of the rat.
1995,
Pubmed Friesner,
Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.
2006,
Pubmed Friesner,
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.
2004,
Pubmed Froestl,
Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists.
1995,
Pubmed Froestl,
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
1995,
Pubmed Gussin,
Binding of muscimol-conjugated quantum dots to GABAC receptors.
2006,
Pubmed
,
Xenbase Halgren,
Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.
2004,
Pubmed Hansen,
Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
2005,
Pubmed Harrison,
Molecular modeling of the GABA(C) receptor ligand-binding domain.
2006,
Pubmed Hinton,
Enantioselective actions of 4-amino-3-hydroxybutanoic acid and (3-amino-2-hydroxypropyl)methylphosphinic acid at recombinant GABA(C) receptors.
2008,
Pubmed
,
Xenbase Jones,
Microscopic kinetics and energetics distinguish GABA(A) receptor agonists from antagonists.
2001,
Pubmed Jones,
Desensitized states prolong GABAA channel responses to brief agonist pulses.
1995,
Pubmed Khasawneh,
Differential mapping of the amino acids mediating agonist and antagonist coordination with the human thromboxane A2 receptor protein.
2006,
Pubmed Khasawneh,
Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets.
2008,
Pubmed Krehan,
Phosphinic, phosphonic and seleninic acid bioisosteres of isonipecotic acid as novel and selective GABA(C) receptor antagonists.
2003,
Pubmed
,
Xenbase Lukasiewicz,
Synaptic mechanisms that shape visual signaling at the inner retina.
2005,
Pubmed Lummis,
A cation-pi binding interaction with a tyrosine in the binding site of the GABAC receptor.
2005,
Pubmed Nehilla,
Neurotransmitter analog tethered to a silicon platform for neuro-BioMEMS applications.
2004,
Pubmed Numano,
Nanosculpting reversed wavelength sensitivity into a photoswitchable iGluR.
2009,
Pubmed Olsen,
GABA A receptors: subtypes provide diversity of function and pharmacology.
2009,
Pubmed Padgett,
Unnatural amino acid mutagenesis of the GABA(A) receptor binding site residues reveals a novel cation-pi interaction between GABA and beta 2Tyr97.
2007,
Pubmed
,
Xenbase Petrini,
Influence of GABAAR monoliganded states on GABAergic responses.
2011,
Pubmed Qian,
Novel GABA responses from rod-driven retinal horizontal cells.
1993,
Pubmed Ragozzino,
Design and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.
1996,
Pubmed
,
Xenbase Saifuddin,
Assembly and characterization of biofunctional neurotransmitter-immobilized surfaces for interaction with postsynaptic membrane receptors.
2003,
Pubmed Sedelnikova,
Mapping the rho1 GABA(C) receptor agonist binding pocket. Constructing a complete model.
2005,
Pubmed Song,
The GABA rho1 subunit interacts with a cellular retinoic acid binding protein in mammalian retina.
2005,
Pubmed Torres,
Identification of a tyrosine in the agonist binding site of the homomeric rho1 gamma-aminobutyric acid (GABA) receptor that, when mutated, produces spontaneous opening.
2002,
Pubmed
,
Xenbase Twyman,
Intraburst kinetic properties of the GABAA receptor main conductance state of mouse spinal cord neurones in culture.
1990,
Pubmed Volgraf,
Allosteric control of an ionotropic glutamate receptor with an optical switch.
2006,
Pubmed Vu,
Activation of membrane receptors by a neurotransmitter conjugate designed for surface attachment.
2005,
Pubmed
,
Xenbase Wang,
Establishing an ion pair interaction in the homomeric rho1 gamma-aminobutyric acid type A receptor that contributes to the gating pathway.
2007,
Pubmed
,
Xenbase
